Consensus Transgene

Stocks

TNG

FR0005175080

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 16:55:00 17/07/2026 BST			5-day change	1st Jan Change
0.7370 ^EUR	+0.82%		-2.64%	-23.23%

06-29	Transgene SA - Special Call
06-25	Oddo BHF Stays Positive on Transgene

Evolution of the Average Target: Transgene

Evolution of the Target Price: Transgene

Changes in Analyst Recommendations: Transgene

3064224d4a08.67nlyvooeFnEyZqmUkMzl95uCpwNnSxsFP6UeF3VIXs.r_ijsIsRVSql_6zABntC8I9ecuVjqEACTbjyMxikEkKn6K_nz203DZXwzw~ee727608ab0248eeca689befce5b943b

Analysts' recommendations: Transgene

06-25	Oddo BHF Stays Positive on Transgene
04-07	Transgene stands out following licensing agreement with NEC Bio
11-27	Oddo BHF Lowers Target Price on Transgene but Remains Upbeat
13/10/25	Transgene and BioInvent International AB Jointly Present a Poster on Transational Data and Updated Clinical Results from the Phase I Study of BT-001	CI
18/09/25	Transgene: analysts reiterate their recommendations after results
17/09/25	The day the Fed resumed its rate cuts
06/11/24	Transgene: Invest Securities remains Buy
15/10/24	Transgene: Invest Securities confirms its Buy recommendation
26/09/24	Transgene: Invest Securities confirms its opinion
06/06/23	Transgene: Invest Securities confirms its Buy rating
05/06/23	Transgene: Invest Securities reiterates its recommendation
22/03/23	Transgene: Invest Securities reduces its target
10/01/23	Transgene: Invest Securities confirms its Buy rating

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TRANSGENE			-	-	+49.25%
	WUXI APPTEC CO., LTD.					+27.64%
	ARGENX SE					+17.91%
	INSMED INCORPORATED					+81.3%
	BIONTECH SE					+33.1%
	WUXI BIOLOGICS (CAYMAN) INC.					+27.13%
	GENMAB A/S					+24.84%
	PHARMAESSENTIA CORPORATION					-10.18%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+14.72%
	EXELIXIS, INC.					-8.92%
	Average					+25.68%
	Weighted average by Cap.					+25.62%

See all sector consensus

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7370EUR

Average target price

1.100EUR

Spread / Average Target

+49.25%

High Price Target

1.100EUR

Spread / Highest target

+49.25%

Low Price Target

1.100EUR

Spread / Lowest Target

+49.25%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7370EUR

Average target price

1.100EUR

Spread / Average Target

+49.25%

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Stock Market
Stocks
TNG Stock
Consensus Transgene

Google lets you customize your preferred sources.

G Google

Choose MarketScreener

G Google

Choose MarketScreener